HopeStage
Back to all studies
Active Not RecruitingNCT06529029

Lower-current seizure therapy versus standard ECT for suicidal thoughts

About this titleRead the official source — NCT06529029
Device studyAges 18–90United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 90 years.

Listed locations
Grand RapidsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 3, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
30
Sponsor
Michigan State University
Sponsor type
University
Study type
Device
Intervention type
Device, Procedure
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 90 Years
Official registry ID
NCT06529029
Official title
Show the full official title

Efficacy of Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy in Remission of Suicidal Ideation

Recruitment & locations

Not recruiting

Grand Rapids

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Michigan State University, a university.

Who can participate?

Listed age limits: 18 years to 90 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies